TARA NASDAQ
Protara Therapeutics, Inc.
1W: -6.2%
1M: -8.1%
3M: -27.3%
YTD: -7.6%
1Y: +42.8%
3Y: +42.4%
5Y: -44.8%
$4.92
-0.05 (-1.01%)
Weekly Expected Move ±5.8%
$5
$5
$5
$5
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-63M
Net Income
-39.4% YoY
$-63M
Free Cash Flow
-56.6% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-34.8%
ROA-32.4%
ROIC-125.2%
Valuation
P/E-3.3
P/B1.2
EV/EBITDA-1.1
Leverage
Debt/Equity0.02
Current Ratio14.58
Interest Cov.-44.6x
Quality Scores
Piotroski F2/9
Altman Z8.03
Beneish M0.00